Atlas FDA

Et Control

FDA premarket approval P210018 · decided 2022-03-17

Approval details

PMA number
P210018
Trade name
Et Control
Generic name
Software option for anesthesia gas machine to achieve and maintain targeted end tidal oxygen and anesthetic agents
Applicant
Datex-Ohmeda, Inc., A General Electric Company
Date received
2021-05-03
Decision date
2022-03-17
Days to decision
318 days
Decision code
APPR
Product code
QSF
Advisory committee
Anesthesiology
Expedited review
No
Location
Madison, WI
Statement
Approval for Et Control indicated for use with the Datex-Ohmeda Aisys CS2 anesthesia system to support clinicians in maintaining the targeted end tidal oxygen and end tidal anesthetic agent concentrations that the clinician sets during an anesthetic procedure, by making multiple, limited adjustments to the fresh gas composition and total flow. The Et Control feature is indicated for patients, 18 years of age and older.The Aisys CS2 anesthesia system and the Et Control feature are intended for pr

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.